Investigator
Hannah Marie Peterson
APERTURE BIO, INC. · funded by NCI
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $1.3M
- First award
- May 20, 2024
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Mar 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- APERTURE BIO, INC.24momentum
OncologyGrant-only
- APERTURE BIO, INC.20momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R43
Cyclic Immunofluorescent Imaging in Live Cells
$405kMar 1, 2025NCIAPERTURE BIO, INC.NIH RePORTER · 11069776 (opens the source filing in a new tab)
- R44
Rapid, Single Cell Proteomic Profiling for Biomarker Development in Precision Oncology
$942kMay 20, 2024NCIAPERTURE BIO, INC.NIH RePORTER · 11247614 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources